Contingency Management for Smoking Cessation Among Veterans With Psychotic Disorders - NCT00508560-98109 (Clinical Trial 178340)
Permalink: http://www.ClinicalConnection.com/exp/ExpandedPatientViewStudy178340.aspx
|
** Please review additional "Nearby Studies" on right ----->
|
|
 |
 |
|
| City: |
|
Seattle |
|
State:
|
|
WA |
| Zip Code: |
|
98109 |
| Conditions: |
|
Nicotine Dependence - Psychotic Disorders |
| Purpose: |
|
This study examines the use of contingent incentives to increase attendance at smoking
cessation treatment sessions by smokers with schizophrenia and other psychoses who want to
quit smoking. We hypothesize that participants randomized to receive contingent rewards for
group attendance will attend more treatment sessions than those in the control group.
|
| Study summary: |
|
Schizophrenia and other psychotic disorders are highly prevalent in the VA population and
are associated with high rates of smoking. Although smoking cessations approaches that work
for non-schizophrenic patients such as behavioral counseling and medications appear to be
efficacious for schizophrenic smokers, a major obstacle in providing adequate treatment is
poor attendance at treatment sessions. Contingency management has been shown to shape
treatment behavior in non-schizophrenic smokers and to shape other behaviors such as cocaine
use and exercise in schizophrenics.
The intention of this project is to examine the use of contingent incentives to increase
attendance at smoking cessation treatment sessions by smokers with schizophrenia and other
psychoses and to compare two different approaches to providing contingent incentives in this
context. Subjects in the experimental condition draw from a fishbowl to obtain tokens when
they attend a smoking cessation treatment session. The number of draws will be based upon
attendance at consecutive sessions. Subjects in the experimental condition receive a set
reward that will not change regardless of attendance at consecutive sessions. We hypothesize
that the participants in the experimental condition will attend more smoking cessation group
therapy sessions than those in the control condition because they will have the possibility,
although not the likelihood, to obtain contingent reinforcement of greater value. |
| Criteria: |
|
Inclusion Criteria:
- All subjects must be diagnosed with schizophrenia or any other psychotic disorder,
bipolar disorder with psychotic features, or major depression with psychotic features
according to the electronic medical record.
- Current nicotine use, defined as smoking 5 or more cigarettes/day for at least 16 of
the past 30 days prior to study screening.
- Prospective subjects must indicate willingness to attend smoking cessation group
therapy.
Exclusion Criteria:
- Any Substance Dependence Disorder (except nicotine dependence) not in remission or
partial remission as determined by review of electronic medical records (current
substance abuse disorder and substance dependence disorder in remission or partial
remission > 1 month are not exclusions).
- Imminent risk for suicide or violence.
- Severe psychiatric symptoms or psychosocial instability likely to prevent
participation in the study protocol (i.e., attendance at scheduled sessions, ability
to read study materials, and/or ability to comprehend interventions).
- Clinically apparent, gross cognitive impairment. |
|
|
|
| Study is available at: |
|
VA Puget Sound Health Care System
Seattle, WA 98109
United States
Primary Contact:
Carol Malte, MSW
Email: Carol.Malte@va.gov
Phone: 206-277-3780
Secondary Contact:
Kevin Wruck
Email: Kevin.Wruck@va.gov
Phone: (206) 277-4872 |
|
|
If you are interested in this clinical trial please use the contact information above. If you would like to get additional information about this clinical trial please visit ClinicalTrials.gov.
|
| Trials Alerts: |
|
If you would like to be
notified of new clinical trials as they become available please
register for a free account.
|
|
| Data Source: |
|
ClinicalTrials.gov |
| Date Processed: |
|
March 15, 2010 |
Modifications to
this listing: |
|
Only selected fields are shown, please use the link
above to view all information about this clinical trial. |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| |
|
|
| |
|
|
| |
|
|
| |
|
|
| |
|
|
| |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Clinical trials are medical research studies designed to test the safety and/or
effectiveness of new drugs, devices, or treatments in humans. These studies are
conducted worldwide for a range of conditions and illnesses. Learn more about
clinical research and participating in a study at
About Clinical Trials.
|
|
|
|
|